Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency

European Heart Journal

Volumn 34, Issue 9, 2013, Pages 676-683

  Lam, Carolyn S P ^a,b   Shah, Amil M ^c   Borlaug, Barry A ^d   Cheng, Susan ^c   Verma, Anil ^e   Izzo, Joseph ^f   Oparil, Suzanne ^g   Aurigemma, Gerard P ^h   Thomas, James D ⁱ   Pitt, Bertram ^j   Zile, Michael R ^k   Solomon, Scott D ^c  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MAYO CLINIC   (United States)

^e JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

^f UNIVERSITY AT BUFFALO   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j UNIVERSITY OF MICHIGAN   (United States)

^k MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

more..

Author keywords

Arterial stiffness; Echocardiography; Hypertension; Ventricular stiffness

Indexed keywords

AMLODIPINE PLUS VALSARTAN; PLACEBO; VALSARTAN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTERY RESISTANCE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; FOLLOW UP; HEART AFTERLOAD; HEART FUNCTION; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART WORK; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VENTRICULAR ARTERIAL COUPLING;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; ARTERIES; BLOOD PRESSURE; CLINICAL TRIALS AS TOPIC; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEX FACTORS; STROKE VOLUME; VASCULAR STIFFNESS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84874689008     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs299     Document Type: Article

References (30)

1. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-1562. (Pubitemid 26154241)
2. Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute. Circulation 2009;119:3070-3077.
3. O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 1990;15:339-347. (Pubitemid 20137587)
4. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003;107:714-720. (Pubitemid 36222599)
5. Mayet J, Hughes A. Cardiac and vascular pathophysiology in hypertension. Heart 2003;89:1104-1109. (Pubitemid 37046861)
6. Borlaug BA, Lam CS, Roger VL, Rodeheffer RJ, Redfield MM. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol 2009;54: 410-418.
7. Starling MR. Left ventricular-arterial coupling relations in the normal human heart. Am Heart J 1993;125:1659-1666. (Pubitemid 23169481)
8. Sunagawa K, Sugimachi M, Todaka K, Kobota T, Hayashida K, Itaya R, Chishaki A, Takeshita A. Optimal coupling of the left ventricle with the arterial system. Basic Res Cardiol 1993;88(Suppl 2):75-90. (Pubitemid 24060019)
9. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker-Boudier HA, Zanchetti A. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-1536.
10. Saba PS, Roman MJ, Ganau A, Pini R, Jones EC, Pickering TG, Devereux RB. Relationship of effective arterial elastance to demographic and arterial characteristics in normotensive and hypertensive adults. J Hypertens 1995;13:971-977.
11. Chantler PD, Lakatta EG, Najjar SS. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. J Appl Physiol 2008;105:1342-1351.
12. Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA. Age- and genderrelated ventricular-vascular stiffening: a community-based study. Circulation 2005; 112:2254-2262. (Pubitemid 41464567)
13. Cohen-Solal A, Caviezel B, Laperche T, Gourgon R. Effects of aging on left ventricular- arterial coupling in man: assessment by means of arterial effective and left ventricular elastances. J Hum Hypertens 1996;10:111-116. (Pubitemid 26101034)
14. Chantler PD, Melenovsky V, Schulman SP, Gerstenblith G, Becker LC, Ferrucci L, Fleg JL, Lakatta EG, Najjar SS. The sex-specific impact of systolic hypertension and systolic blood pressure on arterial-ventricular coupling at rest and during exercise. Am J Physiol Heart Circ Physiol 2008;295:H145-H153.
15. Scantlebury DC, Borlaug BA. Why are women more likely than men to develop heart failure with preserved ejection fraction? Curr Opin Cardiol 2011;26:562-568.
16. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, Lacourciere Y, Hippler SE, Fields H, Naqvi TZ, Mulvagh SL, Arnold JM, Thomas JD, Zile MR, Aurigemma GP; Valsartan in Diastolic Dysfunction (VALIDD) Investigators. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 2007;369:2079-2087. (Pubitemid 46935945)
17. Solomon SD, Verma A, Desai A, Hassanein A, Izzo J, Oparil S, Lacourciere Y, Lee J, Seifu Y, Hilkert RJ, Rocha R, Pitt B; Exforge Intensive Control of Hypertension to Evaluate Efficacy in Diastolic Dysfunction Investigators. Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction. Hypertension 2010;55: 241-248.
18. Janardhanan R, Daley WL, Naqvi TZ, Mulvagh SL, Aurigemma G, Zile M, Arnold JM, Artis E, Purkayastha D, Thomas JD, Solomon SD; VALIDD Investigators. Rationale and design: the VALsartan in Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension. Am Heart J 2006;152:246-252. (Pubitemid 44093403)
19. Hassanein A, Desai A, Verma A, Oparil S, Izzo J, Rocha R, Hilkert R, Seifu Y, Pitt B, Solomon S. EXCEED: exforge-intensive control of hypertension to evaluate efficacy in diastolic dysfunction: study rationale, design, and participant characteristics. Ther Adv Cardiovasc Dis 2009;3:429-439.
20. Sunagawa K, Maughan WL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983;245(5 Pt 1): H773-H780. (Pubitemid 14245481)
21. Kelly RP, Ting CT, Yang TM, Liu CP, Maughan WL, Chang MS, Kass DA. Effective arterial elastance as index of arterial vascular load in humans. Circulation 1992;86: 513-521.
22. Chen CH, Fetics B, Nevo E, Rochitte CE, Chiou KR, Ding PA, Kawaguchi M, Kass DA. Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol 2001;38:2028-2034. (Pubitemid 33116581)
23. Senzaki H, Chen CH, Kass DA. Single-beat estimation of end-systolic pressurevolume relation in humans. A new method with the potential for noninvasive application. Circulation 1996;94:2497-2506. (Pubitemid 26403579)
24. Suga H. Total mechanical energy of a ventricle model and cardiac oxygen consumption. Am J Physiol 1979;236:H498-H505.
25. Suga H, Hayashi T, Shirahata M, Suehiro S, Hisano R. Regression of cardiac oxygen consumption on ventricular pressure-volume area in dog. Am J Physiol 1981;240: H320-H325. (Pubitemid 11139539)
26. Lam CS, Xanthakis V, Sullivan LM, Lieb W, Aragam J, Redfield MM, Mitchell GF, Benjamin EJ, Vasan RS. Aortic root remodeling over the adult life course: longitudinal data from the Framingham Heart Study. Circulation 2010;122:884-890.
27. Mitchell GF, Lacourciere Y, Ouellet JP, Izzo JL Jr, Neutel J, Kerwin LJ, Block AJ, Pfeffer MA. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation 2003;108: 1592-1598. (Pubitemid 37187786)
28. Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS, Lorell BH. Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 1999;34:264-273.
29. Drazner MH. The progression of hypertensive heart disease. Circulation 2011;123: 327-334.
30. Antonini-Canterin F, Enache R, Popescu BA, Popescu AC, Ginghina C, Leiballi E, Piazza R, Pavan D, Rubin D, Cappelletti P, Nicolosi GL. Prognostic value of ventricular-arterial coupling and B-type natriuretic peptide in patients after myocardial infarction: a five-year follow-up study. J Am Soc Echocardiogr 2009;22: 1239-1245.